RT Book, Section
A1 Hughes, Darrel W.
A1 Attridge, Rebecca L.
A2 Attridge, Rebecca L.
A2 Miller, Monica L.
A2 Moote, Rebecca
A2 Ryan, Laurajo
SR Print(0)
ID 57285942
T1 Chapter 5. Advanced Cardiac Life Support
T2 Internal Medicine: A Guide to Clinical Therapeutics
YR 2013
FD 2013
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-174580-2
LK accesspharmacy.mhmedical.com/content.aspx?aid=57285942
RD 2024/04/18
AB 4  rhythms  produce  pulseless  cardiac  arrest:  ventricular  fibrillation  (VF),  pulseless  ventricular  tachycardia  (VT),  pulseless  electrical  activity  (PEA),  &  asystoleKey  elements  to  survival  (chain  of  survival)  in  patient  with  cardiac  arrest  (JAMA  1984;251:1723)  Early  access;  early  cardiopulmonary  resuscitation  (CPR):  compressions,  airway,  breathing  (CAB)  (Circulation  2010;  122:S250);  early  defibrillation  (10%  ↓  in  successful  intervention  for  every  1min  delay);  early  advanced  cardiac  life  support  (ACLS)Other  elements  associated  with  survival  Location  of  cardiac  arrest:  in-hospital  >  community  (3–4-fold  delay  in  initiation  of  pharmacotherapy  for  community  cardiac  arrest);  witnessed  >  unwitnessedInitial  cardiac  rhythmPreexisting  medical  conditionsAdult  cardiopulmonary  arrest  usually  results  from  an  arrhythmia  secondary  to  thrombosis  or  pulmonary  embolismGoals  of  ACLS:  sustained  return  of  spontaneous  circulation  (ROSC),  limiting  end-organ  damage,  survival  to  hospital  dischargeRole  of  drug  therapy:  enhance  chance  of  ROSC,  facilitate  defibrillationPrompt  delivery  of  CPR  followed  by  defibrillation  ↑  survival  in  patients  with  pulseless  VT/VF